Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia

SAN DIEGO, Feb. 21, 2018 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ( " Evofem " or the " Company " ), a biotechnology company developing innovative products to fill women ' s unmet healthcare needs, today announced that the U.S. Food and Drug...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news